Replies to post #9569 on Sorrento Therapeutics Inc (SRNE)

[1776club]

AND WHAT IS WORSE...
Equities research analysts expect that Sorrento Therapeutics, Inc. (NASDAQ:SRNE) will announce sales of $19.85 million for the current fiscal quarter, according to Zacks. Three analysts have provided estimates for Sorrento Therapeutics' earnings, with estimates ranging from $8.36 million to $29.00 million. Sorrento Therapeutics reported sales of $7.72 million in the same quarter last year, which would indicate a positive year-over-year growth rate of 157.1%. The firm is expected to report its next quarterly earnings results on Monday, May 10th.
FOR THE SHORTS...